Clinical Scorecard: Anticipated Effects of Decreasing Federal Support for Syringe Exchange Programs Through Executive Action
At a Glance
Category
Detail
Condition
Key Mechanisms
Syringe exchange programs (SSPs) and medications for opioid use disorder (MOUD) reduce overdose risk and infectious complications through harm reduction services.
Target Population
Care Setting
Key Highlights
Modeling predicts potential outcomes of funding disruptions on mortality among persons who inject drugs, indicating increased overdose rates.
Guideline-Based Recommendations
Diagnosis
Management
Utilize harm reduction services to decrease overdose risk.
Implement specific harm reduction strategies such as naloxone distribution and safe injection education.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Persons who inject drugs in the US
Access to SSPs and MOUD is critical for reducing overdose risk.
Clinical Best Practices
Ensure adequate funding for SSPs to maintain service delivery.
Implement harm reduction strategies to support individuals who inject drugs.
Engage with community stakeholders to enhance the effectiveness of SSPs.
by Kirk B. Fetters, Pranav Padmanabhan, Kristina Yamkovoy, Xiaoyu Guan, Sarah E. Scott, Lauren Kerr, Kathleen Joseph, Gwenyth L. Day, Marina Plesons, Tyler S. Bartholomew, Hansel E. Tookes, Alia Al-Tayyib, Joshua A. Barocas
